Successful visualization of the odor discrimination process in an AI-assisted olfactory sensor
Peer-Reviewed Publication
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 17-Nov-2025 20:11 ET (18-Nov-2025 01:11 GMT/UTC)
NIMS has been developing chemical sensors as a key component of the artificial olfaction technology (olfactory sensors), with the aim of putting this technology into practical use. In this study, explainable AI (XAI) was used to reveal how chemical sensors discriminate among various odorant molecules. The findings may help guide the selection of receptor materials for developing high-performance chemical sensors capable of detecting odorant molecules. The achievement is expected not only to improve the performance of artificial olfaction but also to advance understanding of human olfactory mechanisms. This research was published online in ACS Applied Materials & Interfaces on September 9, 2025.
Inaugural Margot and Tom Pritzker Prize for AI in Science Research Excellence Announces Winners at Conference
UC San Diego researchers developed a machine learning model that accurately predicts skin cancer risk across ancestries, improving equity in early detection and outcomes using genetics, lifestyle, and social factors.
In a real-world clinical trial, published in JAMA Network Open, researchers demonstrate that a fully digital AI zero-cost method for detecting dementia can be scaled across primary care clinics. This breakthrough represents a major step forward in translating AI and patient-reported outcomes into everyday clinical care. By integrating scalable digital tools that operate seamlessly within existing health systems, the research team demonstrated how technology can strengthen early detection and improve outcomes for older adults as well as reduce burdens on primary care teams. The AI tool, which has been in development for more than 10 years at Regenstrief Institute, is a machine learning algorithm that uses natural language processing to analyze data from electronic health records. It identifies information such as memory issues, vascular concerns and other factors linked to dementia.
Lehigh University PhD student Saskia Putri is partnering with Siemens through a two-semester fellowship to develop microgrid technologies that improve the reliability and resilience of data center energy systems. Working under the guidance of civil and environmental engineering professor Farrah Moazeni, Putri is modeling and testing real-time control systems designed to stabilize power for energy-intensive operations such as AI training. The collaboration, part of Lehigh’s Center for Advancing Community Electrification Solutions (ACES), aims to bridge academic innovation and industrial application in next-generation energy infrastructure.
Cambridge, MA, Nov 10th ,2025 — Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced a research collaboration with Eli Lilly (“Lilly”) that the two parties will combine Insilico’s state-of-the-art Pharma.AI platforms with Lilly’s development and disease expertise to jointly discover and advance innovative therapies.
UCLA is the first public research institution on the West Coast with the CellXpress.AI, a research instrument that automates the steps for growing cells and tissue in culture.
Using the new device to grow stem cells into organoids, which mimic organs from the body, enables investigators in both drug development and the basic life sciences to conduct experiments with cellular systems that resemble human biology more closely than animal models do.
The device offers gains in speed, flexibility, efficiency and reproducibility, while reducing tedious manual labor, supercharging UCLA research, as well as research from other academic and industrial collaborators.